Moderna unveils $500m plan for African vaccine facilityModerna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Share XModerna unveils $500m plan for African vaccine facilityhttps://pharmaphorum.com/news/moderna-unveils-500m-plan-for-african-vaccine-facility/
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcastEpisode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply Share XNovartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-amit-nastik-pharma-supply-chain/
After Alexion buy, AZ plans $360m investment in Irish facilitiesAstraZeneca has unveiled plans to build a brand new manufacturing facility at a site in Ireland operated by Share XAfter Alexion buy, AZ plans $360m investment in Irish facilitieshttps://pharmaphorum.com/news/after-alexion-buy-az-plans-360m-investment-in-irish-facilities/
Moderna ramps up EU COVID jab capacity via Lonza dealCapacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by around 300 million doses a year, Share XModerna ramps up EU COVID jab capacity via Lonza dealhttps://pharmaphorum.com/news/moderna-ramps-up-eu-covid-jab-capacity-via-lonza-deal/
FDA pens stinging report on Emergent COVID vaccine plantEmergent BioSolutions’ difficult month has been made worse by an FDA report into its facility in Baltimore, which Share XFDA pens stinging report on Emergent COVID vaccine planthttps://pharmaphorum.com/news/fda-pens-stinging-report-on-emergent-covid-vaccine-plant/
COVID-19 underscores need to boost pharma manufacturing in emerging marketsFor the past year, life science companies around the world worked at breakneck speed to develop and manufacture Share XCOVID-19 underscores need to boost pharma manufacturing in emerging marketshttps://pharmaphorum.com/views-and-analysis/covid-underscores-need-to-boost-pharma-manufacturing-in-emerging-markets/
Bomb scare sparks evacuation of plant making AZ COVID-19 vaccineA plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today Share XBomb scare sparks evacuation of plant making AZ COVID-19 vaccinehttps://pharmaphorum.com/news/bomb-scare-sparks-evacuation-of-plant-making-az-covid-19-vaccine/
Why cell therapy manufacture is a team sportLouis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that Share XWhy cell therapy manufacture is a team sporthttps://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/
Pfizer cut vaccine production targets because of raw material shortage – reportsPfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its Share XPfizer cut vaccine production targets because of raw material shortage – reportshttps://pharmaphorum.com/news/pfizer-cut-vaccine-production-targets-because-of-raw-material-shortage-reports/
